Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 239

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 239
---
00 West Charleston Blvd, #170-659, Las Vegas, NV 89135.                                                                               |

| 119 |

| (2) | Based upon our information and belief. Consists of warrants to purchase an aggregate of 1,160,720,000                                         
 Ordinary Shares (in the form of Depositary Shares). Brio Capital Management LLC, is the investment manager of Brio Capital                    
 Master Fund Ltd. and has the voting and investment discretion over securities held by Brio Capital Master Fund Ltd. Shaye Hirsch,             
 in his capacity as Managing Member of Brio Capital Management LLC, makes voting and investment decisions on behalf of Brio Capital            
 Management LLC in its capacity as the investment manager of Brio Capital Master Fund Ltd. The percentage in this table reflects               
 that the reporting persons may not exercise the warrants to the extent such exercise would cause the reporting persons to beneficially        
 own a number of Ordinary Shares that would exceed 9.99% of our then outstanding share capital following such exercise. The principal business 
 address of Brio Capital Management LLC is 100 Merrick Rd., Suite 401W, Rockville Centre, NY 11570.                                            |

| (3) | Based primarily on the Schedule 13G/A filed by Cavalry Fund                                                                               
 I LP on September 30, 2024, and our information and belief. Consists of (i) warrants to purchase an aggregate of 1,579,290,000 Ordinary   
 Shares (in the form of Depositary Shares) beneficially owned by Cavalry Investment Fund I, LP and (ii) warrants to purchase an aggregate  
 of 90,560,000 Ordinary Shares (in the form of Depositary Shares) beneficially owned by Cavalry Investment Fund LP. Cavalry Fund I         
 Management LLC, the investment manager of Cavalry Fund I LP and Cavalry Investment Fund LP, has voting and investment power               
 over these securities. Thomas Walsh is the managing member of Cavalry Fund I Management LLC, which is the general partner of Cavalry Fund 
 I LP and Cavalry Investment Fund LP. Thomas Walsh disclaims beneficial ownership over these securities. The percentage in this            
 table reflects that the reporting persons may not exercise the warrants to the extent such exercise would cause the reporting persons     
 to beneficially own a number of Ordinary Shares that would exceed 9.99% of our then outstanding share capital following such exercise.    
 The principal business address of the reporting person is 82 E. Allendale Rd., Ste 5B,